Release Date: 14/08/19 11:24 Summary: Appointment of Alternate Director Price Sensitive: No Download Document 794.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%